1h Free Analyst Time
Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Pfizer Inc (Pfizer) discovers, develops, manufactures, and commercializes biopharmaceuticals. The company offers products to treat various conditions such as cardiovascular, metabolic and pain, women’s health, cancer, inflammation, immune disorders, and rare diseases. It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer sells its products through wholesalers, retailers, hospitals, individual provider offices, clinics, government agencies and pharmacies. It has major manufacturing facilities in India, China, Japan, Ireland, Italy, Belgium, Germany, Singapore, and the US. The company provides its products in North America, South America, Asia-Pacific, Australia, Europe, Africa, and the Middle East. Pfizer is headquartered in New York, the US.Pfizer Inc Key Recent Developments
- Apr 18, 2023: Coronavirus (COVID-19) Update: FDA authorizes changes to simplify use of Bivalent mRNA COVID-19 vaccines
- Apr 13, 2023: Pfizer invites shareholders to attend virtual-only 2023 Annual Meeting of Shareholders on April 27
- Apr 04, 2023: Arbutus Biopharma and Genevant Sciences file patent infringement lawsuit against Pfizer/BioNTech
- Mar 14, 2023: Pfizer signs agreement to acquire Seagen for $43bn
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- Takeda Pharmaceutical Co Ltd
- Sanofi
- Novartis AG
- Eli Lilly and Co
- AbbVie Inc
- GSK plc
- Amgen Inc
- Merck & Co Inc
- Dynavax Technologies Corp
- AstraZeneca Plc
- Generex Biotechnology Corp
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson
- Bristol-Myers Squibb Co
- AstraZeneca Plc
- Takeda Pharmaceutical Co Ltd
- Sanofi
- Novartis AG
- F. Hoffmann-La Roche Ltd
- GSK plc
- Dynavax Technologies Corp
- Amgen Inc
- Generex Biotechnology Corp
- Merck & Co Inc
- Johnson & Johnson
- Bristol-Myers Squibb Co
- Eli Lilly and Co
- AbbVie Inc